(S)-ropivacaine multiple interactions EXP 6480464 Emulsions inhibits the reaction [Ropivacaine results in decreased activity of SLC25A29 protein] CTD PMID:35135371 (S)-ropivacaine decreases activity EXP 6480464 Ropivacaine results in decreased activity of SLC25A29 protein CTD PMID:35135371 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A29 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A29 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317685 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A29 mRNA CTD PMID:21570461 , PMID:26377647 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC25A29 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1317684 6480464 beta-methylcholine affects the expression of SLC25A29 mRNA CTD PMID:21179406 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1317685 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SLC25A29 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1317685 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SLC25A29 exon CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO RGD:1317685 6480464 Fenretinide results in decreased expression of SLC25A29 mRNA CTD PMID:28973697 acrylamide decreases expression ISO RGD:1317684 6480464 Acrylamide results in decreased expression of SLC25A29 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1317684 6480464 Aflatoxin B1 results in increased methylation of SLC25A29 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:1317684 6480464 Tretinoin results in decreased expression of SLC25A29 mRNA CTD PMID:33167477 antirheumatic drug increases expression ISO RGD:1317684 6480464 Antirheumatic Agents results in increased expression of SLC25A29 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO RGD:1317685 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of SLC25A29 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1317684 6480464 Arsenic affects the methylation of SLC25A29 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1317684 6480464 Arsenic affects the methylation of SLC25A29 gene CTD PMID:25304211 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC25A29 gene CTD PMID:28931070 benzo[a]pyrene increases expression ISO RGD:1317685 6480464 Benzo(a)pyrene results in increased expression of SLC25A29 mRNA CTD PMID:21569818 benzo[a]pyrene increases methylation ISO RGD:1317684 6480464 Benzo(a)pyrene results in increased methylation of SLC25A29 promoter CTD PMID:27901495 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC25A29 mRNA CTD PMID:18164116 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC25A29 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:1317685 6480464 bisphenol A results in increased expression of SLC25A29 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:1317684 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC25A29 gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:1317685 6480464 bisphenol A results in decreased methylation of SLC25A29 promoter CTD PMID:27312807 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC25A29 mRNA CTD PMID:32479839 bupivacaine multiple interactions EXP 6480464 Emulsions inhibits the reaction [Bupivacaine results in decreased activity of SLC25A29 protein] CTD PMID:35135371 bupivacaine decreases activity EXP 6480464 Bupivacaine results in decreased activity of SLC25A29 protein CTD PMID:35135371 carbon nanotube increases expression ISO RGD:1317685 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1317684 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC25A29 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1317685 6480464 Chlordecone results in increased expression of SLC25A29 mRNA CTD PMID:29980752 choline multiple interactions ISO RGD:1317685 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC25A29 gene CTD PMID:20938992 clobetasol increases expression ISO RGD:1317685 6480464 Clobetasol results in increased expression of SLC25A29 mRNA CTD PMID:27462272 coumestrol decreases expression ISO RGD:1317684 6480464 Coumestrol results in decreased expression of SLC25A29 mRNA CTD PMID:19167446 diazinon increases methylation ISO RGD:1317684 6480464 Diazinon results in increased methylation of SLC25A29 gene CTD PMID:22964155 dicrotophos decreases expression ISO RGD:1317684 6480464 dicrotophos results in decreased expression of SLC25A29 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1317684 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC25A29 mRNA CTD PMID:29391264 folic acid multiple interactions ISO RGD:1317685 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC25A29 gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1317684 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC25A29 gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of SLC25A29 gene CTD PMID:22079235 gemcitabine increases expression ISO RGD:1317684 6480464 Gemcitabine results in increased expression of SLC25A29 mRNA CTD PMID:17039268 hydrogen cyanide decreases expression ISO RGD:1317685 6480464 Hydrogen Cyanide results in decreased expression of SLC25A29 mRNA CTD PMID:33914522 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC25A29 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A29 mRNA CTD PMID:22129741 L-methionine multiple interactions ISO RGD:1317685 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC25A29 gene CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1317685 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A29 mRNA CTD PMID:18313992 leflunomide decreases expression ISO RGD:1317684 6480464 leflunomide results in decreased expression of SLC25A29 mRNA CTD PMID:28988120 , PMID:29427785 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of SLC25A29 mRNA CTD PMID:24136188 levobupivacaine decreases activity EXP 6480464 Levobupivacaine results in decreased activity of SLC25A29 protein CTD PMID:35135371 levobupivacaine multiple interactions EXP 6480464 Emulsions inhibits the reaction [Levobupivacaine results in decreased activity of SLC25A29 protein] CTD PMID:35135371 mepivacaine decreases activity EXP 6480464 Mepivacaine results in decreased activity of SLC25A29 protein CTD PMID:35135371 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC25A29 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A29 mRNA CTD PMID:18164116 , PMID:22129741 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of SLC25A29 mRNA CTD PMID:23439660 ozone multiple interactions ISO RGD:1317685 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC25A29 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC25A29 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1317685 6480464 Acetaminophen affects the expression of SLC25A29 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC25A29 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1317684 6480464 Acetaminophen results in increased expression of SLC25A29 mRNA CTD PMID:25704631 , PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC25A29 mRNA CTD PMID:32680482 perfluorohexanesulfonic acid decreases expression ISO RGD:1317684 6480464 perfluorohexanesulfonic acid results in decreased expression of SLC25A29 mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:1317684 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLC25A29 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC25A29 mRNA CTD PMID:21251948 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1317684 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC25A29 mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:1317684 6480464 perfluorooctanoic acid results in decreased expression of SLC25A29 mRNA CTD PMID:25812627 pirinixic acid multiple interactions ISO RGD:1317684 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC25A29 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1317685 6480464 pirinixic acid results in decreased expression of SLC25A29 mRNA CTD PMID:23811191 potassium cyanide decreases expression ISO RGD:1317685 6480464 Potassium Cyanide results in decreased expression of SLC25A29 mRNA CTD PMID:33914522 progesterone decreases expression ISO RGD:1317684 6480464 Progesterone results in decreased expression of SLC25A29 mRNA CTD PMID:21540246 SB 431542 multiple interactions ISO RGD:1317684 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1317684 6480464 Silicon Dioxide analog results in decreased expression of SLC25A29 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:1317684 6480464 sodium arsenite results in decreased expression of SLC25A29 mRNA CTD PMID:34032870 sulforaphane decreases expression ISO RGD:1317684 6480464 sulforaphane results in decreased expression of SLC25A29 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1317684 6480464 Sunitinib results in decreased expression of SLC25A29 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1317684 6480464 Temozolomide results in increased expression of SLC25A29 mRNA CTD PMID:31758290 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of SLC25A29 mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:1317684 6480464 Testosterone results in increased expression of SLC25A29 mRNA CTD PMID:33359661 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC25A29 mRNA CTD PMID:31150632 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of SLC25A29 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:1317685 6480464 titanium dioxide affects the expression of SLC25A29 mRNA CTD PMID:17656681 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLC25A29 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1317684 6480464 trichostatin A results in decreased expression of SLC25A29 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1317684 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A29 mRNA CTD PMID:27188386 valproic acid increases methylation ISO RGD:1317684 6480464 Valproic Acid results in increased methylation of SLC25A29 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1317684 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A29 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1317684 6480464 Valproic Acid results in decreased expression of SLC25A29 mRNA CTD PMID:23179753 more ... vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC25A29 mRNA CTD PMID:23034163 zidovudine multiple interactions ISO RGD:1317685 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A29 mRNA CTD PMID:18313992